Lyomark Pharma GmbH

Lyomark Pharma GmbH is a supplier of APIs, formulations, and R&D chemicals, specializing in patented drugs, generics, and orphan drugs for the treatment of rare diseases, including sterile injectables and lyophilized formulations packaged in pre-filled syringes, vials, and ampoules. As of the end of 2014, Lyomark had total assets of 6.6 million euros, sales revenue of 7.6 million euros, and a net profit of 850,000 euros.